Prospective study comparing mitomycin C or bevacizumab as adjuvant in trabeculectomy revision by needling.

Purpose: To compare the use of mitomycin C (MMC) or bevacizumab (BEV) as adjunctive in the needling revision of failed trabeculectomy blebs.

Methods: Glaucoma patients with failed trabeculectomy were included. Cystic blebs were excluded.